INVESCO Ltd (IVZ)
28.53
+0.47 (1.67%)
NYSE · Last Trade: Oct 27th, 1:57 AM EDT
News & Press Releases
Which Healthcare ETF Is the Better Buy: Invesco’s Broad RSPH or First Trust’s Biotech FBT?fool.com
FBT has outperformed RSPH by a wide margin recently. The question is whether you want to own the fund that won last year or the one built to hold up over many years.
Via The Motley Fool · October 26, 2026
VOO vs. QQQ: Here's the ETF I'd Personally Buy and Hold for Decadesfool.com
Which of these diversified ETFs has more upside potential?
Via The Motley Fool · October 26, 2026
Invesco’s RSPH or iShares’ IBB: Which Healthcare ETF Is the Better Long-Term Buy?fool.com
RSPH offers broader healthcare exposure with lower volatility and higher dividend yield, while IBB provides concentrated biotech focus with stronger recent returns.
Via The Motley Fool · October 26, 2026
Invesco (IVZ) Q3 earnings: what to expect
Asset management firm Invesco (NYSE:IVZ) will be reporting earnings this Tuesday before the bell. Here’s what you need to know. Invesco met analysts’ revenue...
Via StockStory · October 25, 2026
4 of the Smartest ETFs to Buy When Inflation Is Running Hotfool.com
These funds each provide a different approach to inflation protection in your portfolio.
Via The Motley Fool · October 25, 2026
If the Stock Market Crashes, This Is the First ETF I'm Loading Up Onfool.com
The market has crashed before, and it'll probably happen again. So it's best to have a plan ready.
Via The Motley Fool · October 25, 2026
VanEck Biotech vs. Invesco Healthcare: Which ETF Offers More Potential for Long-Term Growth?fool.com
These two healthcare ETFs offer investors exposure to some of medicine's biggest names, but their different approaches to investing could lead to very different results.
Via The Motley Fool · October 25, 2026
The Nasdaq-100 Had Its Worst Week in 18 Months. History Says the Following Year Has Usually Been Strong.fool.com
Why does the record look so much worse when the dot-com years are counted?
Via The Motley Fool · October 24, 2026
Lower Fees, Higher Growth: Why Cost-Conscious Aerospace Investors May Favor XAR Over PPAfool.com
PPA delivered $2,143 on a $1,000 investment over five years, but carries a higher expense ratio. XAR's lower costs and modified equal-weight approach appeal to different investor priorities.
Via The Motley Fool · October 23, 2026
Schwab's Dividend ETF Just Closed at a Record Without Owning a Single "Magnificent Seven" Stockfool.com
It has topped all seven of those tech giants in 2026, but what happens when they lead again?
Via The Motley Fool · October 23, 2026
Should You Forget the Vanguard S&P 500 ETF (VOO) and Buy the Invesco S&P 500 Equal Weight ETF (RSP) Instead?fool.com
The most common investing strategy is typically to buy the S&P 500.
Via The Motley Fool · October 23, 2026
Seeking Income Without Written Calls, a Hedge Reset Daily: Tuttle Capital Launches the Innovation 100 Income and Hedge ETF (QQDH)
An Actively Managed ETF With Nasdaq-100 Exposure That Seeks Weekly Income From Put Credit Spreads and Uses a Short-Dated Options Hedge Each Trading Day
Via Newsfile · October 23, 2026
This Is the 1 ETF I'd Buy and Hold No Matter What the Market Doesfool.com
For a long-term investor, this ETF is a must-own.
Via The Motley Fool · October 23, 2026
Invesco Pharmaceuticals ETF vs. iShares Biotechnology ETF: Which Is the Better Buy?fool.com
Here's how pharmaceutical stocks compare to biotech in terms of risk, rewards, and costs.
Via The Motley Fool · October 23, 2026
There's a New Q in Town: Invesco's ETF Targets International Innovatorsmarketbeat.com
Invesco recently launched QQI, an ETF tracking the Nasdaq International Innovators 100 Index, offering tech- and healthcare-heavy exposure to non-U.S. growth companies with higher costs and lower liquidity than QQQ.
Via MarketBeat · October 22, 2026
History Says This Is the Smartest Dividend ETF to Buy With $1,000 Right Nowfool.com
If the market corrects, this ETF shines.
Via The Motley Fool · October 22, 2026
Big Pharma vs. Breakthrough Biotech: Which ETF Has More Upside for Investors?fool.com
Both ETFs offer investors a way to profit from advances in medicine, but a closer look reveals a clear winner.
Via The Motley Fool · October 22, 2026
3 Volatile Stocks We Find Risky
A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south. While some investors embrace risk, mistakes can be...
Via StockStory · October 19, 2026
Moderna Just Joined the Nasdaq-100. Here's What That Means for Investors.fool.com
It was a head-turning headline. Here's why the market was buzzing.
Via The Motley Fool · October 18, 2026
Tech Stock Sell-Off: 1 Unstoppable ETF to Buy on the Dip in 2026fool.com
The Invesco QQQ Trust is still a reliable long-term investment for growth-oriented investors.
Via The Motley Fool · October 17, 2026
The Defense ETF Duel: Old Guard Aerospace or Next-Gen Tech?fool.com
Invesco's $7.4 billion fund delivers higher dividends and lower volatility, while First Trust's concentrated 39-holding portfolio offers tech-heavy exposure including Palantir and SpaceX.
Via The Motley Fool · October 16, 2026
Expecting a Market Correction? This Mega-Cap ETF Deserves a Spot on Your Watchlistmarketbeat.com
Nearly 75% of Americans expect a correction, survey finds. The Invesco S&P 500 Top 50 ETF (XLG) offers exposure to mega-cap growth stocks that could fall more, then rebound.
Via MarketBeat · October 16, 2026
Is It Really "Safe" to Invest in Tech ETFs Right Now? Here's What History Suggests.fool.com
Tech stocks could crash any day now -- but they also might not be overpriced.
Via The Motley Fool · October 15, 2026
Failed Breakout in Tech? 3 Sectors Leading the Market Rotationmarketbeat.com
QQQ's failed breakout and weak breadth have investors watching utilities (XLU), consumer staples (XLP), and energy (XLE), all showing recent outperformance as capital rotates from growth stocks.
Via MarketBeat · October 15, 2026
A Staggering 84% of S&P 500 Stocks Are Now in Correction Territory, and History Says This Foreshadows Disaster for Wall Streetfool.com
The stock market may be on the verge of a tipping point.
Via The Motley Fool · October 15, 2026